Pharma-Bio Serv (PBSV) EBT Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Pharma-Bio Serv (PBSV) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 94.00 |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 2,401.00 |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 359.00 |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 467.00 |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 140.00 |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 61.00 |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 428.00 |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | -250.00 |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 499.00 |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -370.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -370.00 |
| Jan 31, 2026 | -1,198.00 |
| Oct 31, 2025 | -478.00 |
| Jul 31, 2025 | -1,726.00 |
| Apr 30, 2025 | -157.00 |
| Jan 31, 2025 | -671.00 |
| Oct 31, 2024 | 8,506.00 |
| Jul 31, 2024 | -5,838.00 |
| Apr 30, 2024 | -1,377.00 |
| Jan 31, 2024 | -1,799.00 |
| Oct 31, 2023 | -436.00 |
| Jul 31, 2023 | 31.00 |
| Apr 30, 2023 | -107.00 |
| Jan 31, 2023 | 95.00 |
| Oct 31, 2022 | -505.00 |
| Jul 31, 2022 | -230.00 |
| Apr 30, 2022 | -946.00 |
| Jan 31, 2022 | -415.00 |
| Oct 31, 2021 | -9,502.00 |
| Jul 31, 2021 | 2,965.00 |